Deep Tech Startups

Genespire is a life sciences company backed by multiple venture capital investors including Sofinnova Partners, XGEN Venture, CDP Venture Capital, and Indaco Venture Partners. Based on the investor page content, the company operates in the biotech and life sciences sector.

4 investors

Georgiamune is a biopharmaceutical company developing targeted immunomodulator drugs that activate or down-modulate immune signaling pathways to treat cancer and autoimmune diseases. It operates a target discovery platform that supports a pipeline of first-in-class assets.

4 investors

geoSurge develops infrastructure and tools for generative AI visibility, helping brands measure and manage how AI systems represent and recall their content. The company serves enterprise brands and operates in the adtech and AI/ML space.

4 investors

Ginkgo Bioworks builds autonomous labs that accelerate bioengineering for applications in pharmaceutical, agricultural, and industrial biotechnology. The company serves biopharma, agritech, and industrial biotech companies seeking to engineer organisms at scale.

4 investors

GlobalLogic is a digital engineering services company that helps clients with cloud migration, AI, data engineering, DevOps, and digital transformation, working through partnerships with major technology providers. It serves enterprise organizations across asset-heavy and other industries at the intersection of data, design, and engineering.

4 investors

Nexoplex Bio develops immunotherapies that target tumor cells through recognition of HLA-peptide complexes using multi-specific antibodies, addressing tumor types including lung, gastric, esophageal, head and neck, cervical cancers, and lung squamous cell carcinoma. The company works at the intersection of cancer genomics and immunotherapy and is based at MBC Biolabs in San Carlos, California.

4 investors

Grove Biopharma develops Bionic Biologics, a synthetic drug modality that combines biologic and synthetic design to create cell-permeable molecules targeting intracellular protein-protein interactions. The platform aims to produce therapeutics for patients with cancer, neurodegenerative diseases, and rare disorders.

4 investors

H3X designs and manufactures advanced electric motors for industrial applications. The company operates a full-stack engineering facility with in-house manufacturing capabilities including CNC machining, power electronics labs, and test cells.

4 investors

Haiqu develops quantum computing software that enables practical applications across physics simulation, market modeling, and materials design. The company targets enterprises and research teams seeking to accelerate quantum computing initiatives and applications.

4 investors

Hardt develops hyperloop technology as a sustainable transportation solution that aims to overcome distance barriers.

4 investors

HAYA Therapeutics develops precision RNA medicines that target long non-coding RNAs (lncRNAs) in the regulatory genome to reprogram disease at the level of cell state, with a lead program in cardiac fibrosis and work in obesity and metabolic disease. The biotech company builds a regulatory genome platform to discover tissue- and cell-specific lncRNA targets and turn them into oligonucleotide-based therapies.

4 investors

Helicity Space develops the Helicity Drive, a scalable fusion propulsion engine designed to power deep-space vehicles for faster, reusable, and more fuel-efficient travel. The company targets science, exploration, commercial space, and national security applications enabling deep-space transport and off-world resource use.

4 investors

Hexagon Bio develops novel payload mechanisms for antibody-drug conjugates (ADCs) aimed at overcoming resistance to current cancer treatments and expanding ADC indications. The company focuses on targeted cytotoxic therapy for cancer, drawing on human therapeutics derived from metagenomes.

4 investors

Hololight builds enterprise XR pixel-streaming technology that renders AR and VR applications on external workstations or servers and sends only pixels to headsets, keeping data off the device. Its products include the Hololight Hub orchestration platform, streaming runtime, and an integrated 3D Viewer for industrial and engineering teams working with complex 3D models.

4 investors

HotHouse Therapeutics uses AI combined with plant bioengineering to discover and produce complex natural-product-based molecules, including vaccine adjuvants and small-molecule therapeutics, for pharma, biotech, and global health. Through its BotanAI and BotanBio platforms, it engineers plants as biofactories to synthesize new-to-nature compounds.

4 investors

Human Archive is a data lab that collects, labels, and synchronizes multimodal sensor data (video, audio, tactile, motion capture) from 100,000+ contributors across homes, hospitality, agriculture, industrial, construction, and retail settings. The company provides foundational infrastructure for research and application development in human movement understanding, automation of manual labor, and advances in neuroscience and spatial computing.

4 investors

Hyperspec AI develops generative AI data pipelines and world models that combine LiDAR, camera, GPS, and IMU sensor data to produce real-time HD maps and 3D spatial representations. Its geospatial and ML infrastructure serves applications such as autonomous vehicle navigation, smart city planning, industrial automation, and construction monitoring.

4 investors

Idein develops Actcast, an edge AI platform that runs deep learning on low-cost edge devices (such as Raspberry Pi) with a marketplace of vendor apps for collecting and analyzing real-world data. The platform serves enterprises across industries like automotive, retail, manufacturing, and logistics adopting AI/IoT solutions, primarily in Japan.

4 investors

Ignota Labs uses SAFEPATH, a proprietary AI platform combining machine learning with bioinformatics and cheminformatics data, to identify and resolve drug safety and toxicity problems. It focuses on drugs that failed in preclinical, Phase 1, or Phase 2 clinical trials due to safety issues, aiming to turn them around and bring them to patients faster.

4 investors

Illuminant Surgical develops an AI-powered real-time anatomical projection system called Skylight for spine surgery and interventional procedures, using computer vision and projection mapping to display medical imaging directly onto patients. The system is designed for surgical professionals across hospitals, ambulatory surgical centers, and specialty clinics to improve surgical guidance and workflow efficiency.

4 investors

ImmunoForge is a South Korean drug development company that builds a pipeline of therapeutics based on its ELP (elastin-like polypeptide) half-life extension platform and a blood-brain-barrier shuttle platform (LMT15). Its programs include candidates for chronic myelogenous leukemia (KF1601) and Duchenne muscular dystrophy cardiomyopathy (Pemziviptadil).

4 investors

Indicio builds identity infrastructure based on verifiable credentials and authenticated biometrics, letting organizations verify a person or document once and reuse cryptographic proof across ecosystems. It serves banking/KYC, travel and borders, government/citizen ID, education, and AI agent identity use cases, with support for standards such as SD-JWT VC, W3C VC, mDL/mDOC, and OpenID4VP.

4 investors

Inertia develops laser systems and fuel targets for inertial confinement fusion power generation. The company aims to commercialize fusion energy technology for grid-scale electricity production.

4 investors

Infinite Orbits is a NewSpace company providing in-orbit satellite services for geostationary operators, including asset inspection, satellite life extension, and end-of-life management. Its spacecraft are powered by an autonomous vision-based navigation solution.

4 investors